Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Part I. General subjects
-
1. Need for drug delivery systems 1
- Prof. Ana Catarina Silva
-
2. Need for drug delivery systems 2
- Prof. João Nuno Moreira
-
3. Routes of drug delivery
- Prof. Dr. Sven Stegemann
-
4. Transporters in drug delivery
- Dr. Pravin Shende
-
5. The theory and applications of controlled release principles
- Dr. Michael J. Rathbone
- Part II. Routes for drug delivery
-
6. Oral drug delivery
- Dr. Vineet Kumar Rai
-
7. Transdermal drug delivery
- Prof. Sabine Szunerits
-
8. Pulmonary drug delivery
- Prof. Anthony J. Hickey
-
9. Gastrointestinal drug delivery
- Prof. Susan Hua
-
10. Mucoadhesive drug delivery systems
- Dr. Panoraia I. Siafaka
-
11. Ocular drug delivery
- Prof. Emily Dosmar
-
12. Vaginal and uterine drug delivery
- Prof. José Luis Arias Mediano
-
13. Drug-eluting implants
- Dr. Aliasger K. Salem
- Part III. Materials for drug delivery
-
14. Polymers as nanocarriers for controlled drug delivery
- Prof. Dr. Marcelo Calderón
-
15. Polymeric gels for drug delivery
- Dr. G. Roshan Deen
- Ms. Dora Safar
-
16. Liposomes as a drug delivery system
- Dr. G. Roshan Deen
- Ms. Bushra Hasan
- Ms. Renad AlAnsari
-
17. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC)
- Prof. Ana Catarina Silva
-
18. Micellar drug delivery
- Prof. Francesco Cellesi
-
19. Nanocrystals in drug delivery
- Prof. Eliana Souto
-
20. Layer-by-layer assemblies for drug delivery
- Prof. Szczepan Zapotoczny
-
21. Inorganic nanostructured interfaces for therapeutic delivery
- Prof. Tejal Desai
-
22. Inorganic porous drug delivery carriers
- Prof. Jessica Rosenholm
- Part IV. Specifics of drug delivery
-
23. Delivery of genes and nucleotides
- Prof. Esam Yahya
-
24. Vaccine delivery
- Prof. Sevda Şenel
- Part V. Drug delivery in various diseases
-
25. Drug delivery for cancer therapeutics
- Prof. Tejraj Aminabhavi
-
26. Nanomedicines for brain diseases
- Prof. Giovanni Tosi
-
27. Drug delivery to the colon
- Prof. Susan Hua
-
28. Role of the lymphatic system in drug absorption
- Dr. Kishor M. Wasan
Printable Handouts
Navigable Slide Index
- Introduction
- Learning objectives
- The need for targeted drug delivery systems
- What are liposomes and what are their advantages?
- What are liposomes?
- Why are liposomes preferred?
- Examples of liposomal drug delivery systems in the market
- Types of liposomal drug delivery systems
- Conventional liposomes
- Steric-stabilized liposomal drug delivery systems (1)
- Steric-stabilized liposomal drug delivery systems (2)
- Ligand-targeted liposomal drug delivery systems
- Combination: the newer generation of liposomal drug delivery system
- Summary of liposomal drug delivery system types
- Combination: the newer generation of liposomal drug delivery system
- The reticuloendothelial system and clearance
- Opsonin and vesicle destabilization
- Enhanced permeability and retention effect (EPR)
- Accelerated blood clearance effect (ABC)
- Complement activation-related pseudo allergy (CAPRA)
- Solutions to CARPA
- Thank you
Topics Covered
- Types of liposomes
- Advantages of liposomes for drug delivery
- Doxil
- DaunoXome
- Sterically-stabilized liposomes
- Ligand-targeted liposomes
- Polyethylene glycol (PEG)
- Challenges with liposomes
Talk Citation
Deen, G.R., Hasan, B. and AlAnsari, R. (2023, September 28). Liposomes as a drug delivery system [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/ZNRZ2514.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. G. Roshan Deen has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
- Ms. Bushra Hasan has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
- Ms. Renad AlAnsari has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Liposomes as a drug delivery system
Published on September 28, 2023
17 min
A selection of talks on Clinical Practice
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, I'm Renad AlAnsari from
the School of Medicine at
the Royal College of
Surgeons in Ireland,
Medical University of Bahrain.
My colleague, Bushra and
I are attached to
the Materials for
Medicine Research Group
led by Dr. Roshan Deen.
The main research focus of
our group is the development
of new materials like stimuli
responsive hydrogels,
nanocomposites, and
green nanoparticles for
biomedical applications.
In this lecture, we will
be talking about the use
of liposomes as drug
delivery systems.
I'll be presenting the first
section of this lecture,
and Bushra will be presenting
the second section.
0:38
By the end of this lecture,
you should be able
define liposomes
and list their advantages.
Recall examples of liposomal
drug delivery systems
in the market and what
they're used for.
List the different types of
liposomal drug delivery systems
and explain how
each one functions.
Finally, list and
understand the challenges
to using liposomes as
drug delivery systems.
1:03
Now we're going to talk
about the need for
targeted drug delivery systems.
In the treatment of disease
the drug or the therapeutic
agent needs to be
available at the target site
and at the right concentration.
If the pharmacokinetics is poor,
the bioavailability of
the drug is limited and
could lead to toxicity
of tissues at off sites.
Now this is where the importance
of nanotechnology
and nanomedicine
is fully recognized in
the development of targeted
drug delivery systems.
Nanotechnology plays
a very important role in
translational research,
particularly in the
field of medicine.
Using this technology,
the disease can be
diagnosed and treated
at the clinical level.
Nanoparticles and
liposomes are widely
used in the development of
targeted drug delivery and
gene delivery systems
for the delivery of
various drugs and genes to
the target sites
in the human body.